Back to Search

Assessment of molecular residual disease (MRD) using serial circulating tumor DNA in the peripheral blood of breast cancer patients


  • Protocol Number: 202106128
  • Principal Investigator: Davis, Andrew
  • Cancer Types: Breast

For more information on this trial, contact us here:

Phone
800-600-3606
Email
[email protected]